Aragen BioSafety Solutions is an experienced GLP-compliant non-clinical testing partner with over 30 years of history in conducting safety assessment studies. From designing a complete study program to running every single test, Aragen BioSafety Solutions can support a broad range of toxicology requirements. Safety assessment studies are performed in compliance with global regulatory guidelines such as ICH, FDA, EMA, EU, OECD, OPPTS, JMAFF, and CIB. We work in a collaborative manner using our expertise to accomplish the safety assessment of your product.
Rely on our toxicology testing capabilities when it comes to single-dose and repeat-dose study designs (subacute/chronic). Our scientific and operational teams support study execution and data delivery in accordance with project timelines and regulatory requirements. They can implement all dose routes including oral gavage, dietary, dermal, inhalation, and parenteral in all laboratory animals (rats, mice, rabbits, guinea pigs, hamsters, dogs, and NHP).
All animal experiments are reviewed and approved by the Institutional Animal Ethics Committee (IAEC). Our vivarium is approved by the CCSEA, Government of India and accredited by AAALAC. Historical data accumulated over the years is available on in-life parameters, clinical and anatomic pathology, genetic toxicology, and DART studies.
Acute Six Pack / Single-Dose Toxicity
Repeat Dose & Chronic Studies in Rodents and Non-rodents
